Escherichia coli pyomyositis: An emerging infectious disease among patients with hematologic malignancies

Clinical Infectious Diseases

Volumn 50, Issue 3, 2010, Pages 374-380

  Vigil, Karen J ^a   Johnson, James R ^d   Johnston, Brian D ^d   Kontoyiannis, Dimitrios P ^c   Mulanovich, Victor E ^c   Raad, Issam I ^c   Dupont, Herbert L ^b   Adachi, Javier A ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPOTENSION; INTENSIVE CARE; LABORATORY TEST; MALE; MULTILOCUS SEQUENCE TYPING; NEUTROPENIA; NONHUMAN; OUTCOME ASSESSMENT; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; PYOMYOSITIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; COMMUNICABLE DISEASES, EMERGING; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; FLUOROQUINOLONES; GENOTYPE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; PYOMYOSITIS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; VIRULENCE FACTORS;

EID: 75749136897     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649866     Document Type: Article

References (24)

1. 1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39(3):309-317. (Pubitemid 39050477)
2. Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neu-tropenic cancer patients. Int J Antimicrob Agents 2007;30(Suppl 1): S51-S59.
3. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 2003;5(5):449-456.
4. Barbot R, Morand C, Skopinski S, Albisson E, Portron Y, Coutant G. Pyomyositis of adductor muscles caused by Escherichia coli in an im-munocompetent patient living in a temperate climat. Rev Med Interne 2009.
5. Brook I, Frazier E. Aerobic and anaerobic microbiology of pyomyositis. Infect Dis Clin Practice 1999;8(5):252-256.
6. Chiu SK, Chang FY. Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia. Int J Infect. Dis 2008; 13(3):e85-e87.
7. Cone LA, Lamb RB, Graff-Radfbrd A, et al. Pyomyositis of the anterior tibial compartment. Clin Infect Dis 1997;25(1):146-148.
8. 8. Hall RL, Callaghan JJ, Moloney E, Martinez S, Harrelson JM. Pyomyositis in a temperated climate presentation, diagnosis and treatment. J Bone Joint Surg Am 1990;72:1240-1244. (Pubitemid 20343173)
9. Johnson JR, Gajewski A, Lesse AJ, Russo TA. Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol 2003;41(2):5798-5802.
10. Jou IM, Chiu NT, Yang CY, Lai KA. Pyomyositis-with special reference to the comparison between extra-and intrapelvic muscle abscess. Southeast Asian J Trop Med Public Health 1998;29:835-840.
11. 11. Lortholary O, Jehl F, Petitjean O, Cohen P, Tarral E, Guillevin L. Poly-microbial pyomyositis and bacteremia in a patient with AIDS. Clin Infect Dis 1994; 19(3):552-553. (Pubitemid 24286969)
12. Tumeh SS, Butler GJ, Maguire JH, Nagel JS. Pyogenic myositis: CT evaluation. J Comput Assist Tomogr 1988;12:1002-1005.
13. Vilades C, Garcia-Queralt R, Rivas I, Vidal F, Richart C. Pyomyositis due to Escherichia coli in a patient infected by HIV. Br J Rheumatol 1994;33(4):404-4055.
14. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-4558.
15. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261-272.
16. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhaneld GG. Epidemic clonal groups of Escherichia coli as a cause of antimi-crobial-resistant urinary tract infections in Canada (2002-2004). An-timicrob Agents Chemother 2009;53(7):2733-2739.
17. Vigil KJ, Adachi JA, Aboufaycal H, et al. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 2009; 37: 741-745.
18. Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli 0157: H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006;3(1):59-67.
19. 19. Falagas ME, Rafailidis PI, Kapaskelis A, Peppas G. Pyomyositis asso-ciated with hematological malignancy: case report and review of the literature. Int J Infect Dis 2008; 12(2):120-125. (Pubitemid 351249177)
20. 20. Chiedozi LC. Pyomyositis: review of 205 cases in 112 patients. Am J Surg 1979;137(2):255-259. (Pubitemid 9092125)
21. Crum NF. Bacterial pyomyositis in the United States. Am J Med 2004;117(5):420-128.
22. Cagnacci S, Guaico L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups 025: H4-ST 131 and 015:K52:H1 causing community-acquired uncompli-cated cystitis. J Clin Microbiol 2008;46(8):2605-2612.
23. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Interconti-nental emergence of Escherichia coli clone 025:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61(2):273-281.
24. Clermont O, Lavollay M, Vimont S, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phy-logenetic subgroup. J Antimicrob Chemother 2008;61(5):1024-1028.